Skip to content
Study details
Enrolling now

Pilot Study of BCAA on Sleep

Portland VA Medical Center
NCT IDNCT03990909ClinicalTrials.gov data as of Apr 2026
Target enrollment

300

Study length

about 6.8 years

Ages

18–89

Locations

1 site in OR

About this study

This trial is testing if Branched Chain Amino Acids (BCAA) can improve sleep in people with Traumatic Brain Injury. Participants will take BCAA or a placebo twice daily for 21 days and their sleep, brain function, and pain levels will be measured before and after the treatment period.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Branched Chain Amino Acids
  • 2.Microcrystalline Cellulose
  • 3.Rice Protein
Routeoral

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low5%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Drug routes

oral (Oral Powder)

Endpoints

Secondary: Change in Insomnia Severity Index (ISI)